Gliolan 30 mg/ml powder for oral solution. clinical trials

A Phase 1 Single Center Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy

This study is looking at a new treatment for a type of brain tumour called high-grade glioma. It combines a special light-sensitive medicine with ultrasound. Researchers want to see how safe this treatment is before surgery and standard care.

Clinical safety study on 5-Aminolevulinic acid (5-ALA) in children and adolescents with brain tumors (5-ALA in children and adolescents)

This study looks at a special dye called Gliolan, also known as 5-ALA, used during brain tumour surgery in children and teenagers. Doctors want to see how safe it is and how well it helps them see the tumour. It's an early-stage study to gather important information.

Evaluation of the feasibility of PD L 506 for stereotactic interstitial photodynamic therapy (iPDT) in adult patients with newly diagnosed supratentorial IDH wild-type glioblastoma